Compare MBUU & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBUU | NPCE |
|---|---|---|
| Founded | 1982 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.4M | 536.6M |
| IPO Year | 2013 | 2021 |
| Metric | MBUU | NPCE |
|---|---|---|
| Price | $28.32 | $16.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $32.20 | $18.33 |
| AVG Volume (30 Days) | ★ 302.1K | 172.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 127.74 | 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $807,561,000.00 | $99,986,000.00 |
| Revenue This Year | $2.14 | $0.90 |
| Revenue Next Year | $12.78 | $24.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $23.84 | $7.56 |
| 52 Week High | $39.65 | $19.60 |
| Indicator | MBUU | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 57.17 | 50.03 |
| Support Level | $28.10 | $15.42 |
| Resistance Level | $29.79 | $17.49 |
| Average True Range (ATR) | 1.32 | 0.88 |
| MACD | 0.25 | -0.04 |
| Stochastic Oscillator | 77.47 | 30.71 |
Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.